News about Global Pharma

Myovant Sciences and Accord Healthcare to commercialize ORGOVYX in Europe

“We are proud to launch ORGOVYX in Europe, as an addition to our specialty brand offerings,” said Binish Chudgar, Managing Director of Accord.

Global Pharma | 12/05/2022 | By Content editor

New biotech Kelonia launched

Kelonia Therapeutics is the newest biotech to hit the pharma scene after receiving $50 million in start-up money.

Global Pharma | 30/04/2022 | By Sudeep Soparkar

Phosplatin with NIH start patient dosing in stage 2 preliminary of PT-112

Phosplatin Therapeutics Inc., a clinical stage pharmaceutical company, announced the first patient has been treated in a phase 2 clinical trial of the company's lead therapeutic candidate, PT-112, in patients with recurrent thymic epithelial tumours (TETs), specifically thymoma and thymic carcinoma.

Global Pharma | 15/04/2022 | By Sudeep Soparkar

Kyttaro and Lily come together to get license deal

UK-based startup Kyttaro and Eli Lilly have announced a new licensing deal.

Global Pharma | 14/04/2022 | By Sudeep Soparkar

US FDA approval: Lupin can now market its generic drugs

In its recent statement Lupin has said that it received approval from the US health regulator to market Efinaconazole topical solution, used to treat fungal toenail infections, in the American market

Global Pharma | 07/03/2022 | By Darshana

UK-India innovation centre kick-starts to create a ?hot spot? for sustainable cooling innovation

The Centre of Excellence in Sustainable Cooling and Cold-Chain will conduct state-of-the-art applied research in food and vaccine distribution, supporting the roll-out of affordable, energy resilient, low emission cold-chain systems in India

Global Pharma | 04/03/2022 | By Darshana

As US FDA lifts clinical hold, Covaxin to be evaluated as COVID-19 vaccine candidate in US

Covaxin (BBVI52), which has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is an investigational vaccine candidate product in the US

Global Pharma | 22/02/2022 | By Darshana

With its Ascent Development Services merger, PharmaLex extends reach to Japan, East Asia and Southeast Asia

he Ascent merger offers access to an attractive client portfolio and adds substantially to PharmaLex?s global footprint, not only in the Japanese market but in other key markets throughout East and Southeast Asia. With deep roots in Asia, Ascent can act as a true partner in the region and, through the merger with PharmaLex

Global Pharma | 10/02/2022 | By Darshana

DGFT removes restrictions on syringe exports

The government has removed restrictions on exports of syringes with immediate effect, according to a notification. Restrictions were imposed last year in the wake of the COVID-19 pandemic

Global Pharma | 04/02/2022 | By Darshana

Aurobindo and Unichem recall products in US market

Aurobindo Pharma and Unichem Laboratories are recalling different products in the US market, the world's largest market for medicines, due to manufacturing issues. As per the latest enforcement report issued by the US Food and Drug Administration (FDA), Aurobindo's US-based unit is recalling 7,296 containers of hypertension drug Carvedilol tablets

Global Pharma | 08/12/2021 | By Darshana